MILDRED ADAMS, Ph.D.; MARSCHELLE H. POWER, Ph.D.; WALTER M. BOOTHBY, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
Several attempts have been made to discover specific metabolic abnormalities in subjects with myasthenia gravis. The results in general have been contradictory and therefore inconclusive. The therapeutic value of glycine in this disease has caused a renewed interest in such studies, although the majority of the more recent investigations have dealt chiefly with the effect of glycine on the excretion of creatinine and creatine.
This investigation was undertaken, accordingly, to gain more complete information concerning the metabolism of patients with myasthenia gravis both before and during the administration of glycine. Complete studies in which the food, urine, and feces have
ADAMS M, POWER MH, BOOTHBY WM. METABOLISM STUDIES IN MYASTHENIA GRAVIS BEFORE AND DURING THE ADMINISTRATION OF GLYCINE*. Ann Intern Med. 1936;9:1330–1337. doi: https://doi.org/10.7326/0003-4819-9-10-1330
Download citation file:
Published: Ann Intern Med. 1936;9(10):1330-1337.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use